Companies / Core Scientific, Inc./tx / Activity
Activity — Core Scientific, Inc./tx
42 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 26, 2026 | Smith Stephen M Director | Grant | Common Stock | $0 | +19K | 18,961 <0.01% of shares | low |
| May 20, 2026 | Duchene Todd M Executive | Grant | Common Stock | $0 | +139K +7.07% | 2,098,895 0.65% of shares | low |
| Mar 31, 2026 | Duchene Todd M Executive | Grant | Common Stock | $0 | +217K +11.18% | 2,154,741 0.67% of shares | low |
| Feb 4, 2026 | Booth Jeffrey David Director | Grant | Common Stock | $0 | +19K +9.49% | 214,262 0.07% of shares | low |
| Feb 4, 2026 | Crain Elizabeth Director | Grant | Common Stock | $0 | +19K +39.71% | 65,348 0.02% of shares | low |
| Feb 4, 2026 | Weiss Eric Stanton Director | Grant | Common Stock | $0 | +19K +8.19% | 245,262 0.08% of shares | low |
| Feb 4, 2026 | Rozov Yadin Director | Grant | Common Stock | $0 | +19K +4.26% | 454,162 0.14% of shares | low |
| Feb 4, 2026 | Levy Jordan Director | Grant | Common Stock | $0 | +19K +6.05% | 325,462 0.10% of shares | low |
| Dec 31, 2025 | Sullivan Adam Taylor CEO | Grant | Common Stock | $0 | +159K +3.65% | 4,523,244 1.41% of shares | low |
| Dec 31, 2025 | Duchene Todd M Executive | Grant | Common Stock | $0 | +56K +2.76% | 2,077,880 0.65% of shares | low |
| Dec 30, 2025 | Rozov Yadin Director | Gift | Common Stock | $0 | -40K -8.43% | 435,587 0.14% of shares | low |
| May 4, 2026 | Duchene Todd M Executive | Sell | Common Stock | $2.2K | -100 -0.01% | 1,980,348 0.62% of shares | low |
| Jun 15, 2026 | Duchene Todd M Executive | Sell | Common Stock | $2.9K | -100 -0.00% | 2,058,895 0.64% of shares | low |
| Apr 13, 2026 | Duchene Todd M Executive | Sell | Common Stock | $7.6K | -400 -0.02% | 2,027,089 0.63% of shares | low |
| May 18, 2026 | Duchene Todd M Executive | Sell | Common Stock | $9.5K | -400 -0.02% | 1,960,348 0.61% of shares | low |
| Jun 1, 2026 | Duchene Todd M Executive | Sell | Common Stock | $35.0K | -1K -0.06% | 2,087,595 0.65% of shares | low |
| May 11, 2026 | Duchene Todd M Executive | Sell | Common Stock | $59.3K | -3K -0.13% | 1,977,748 0.62% of shares | low |
| Jun 22, 2026 | Duchene Todd M Executive | Sell | Common Stock | $71.7K | -2K -0.12% | 2,048,895 0.64% of shares | low |
| Jun 1, 2026 | Duchene Todd M Executive | Sell | Common Stock | $90.5K | -3K -0.15% | 2,084,395 0.65% of shares | low |
| Mar 9, 2026 | Weiss Eric Stanton Director | Buy | Common Stock | $101.7K | +7K +2.85% | 252,262 0.08% of shares | medium |
| Jun 8, 2026 | Duchene Todd M Executive | Sell | Common Stock | $122.0K | -5K -0.22% | 2,068,895 0.64% of shares | medium |
| Jun 8, 2026 | Duchene Todd M Executive | Sell | Common Stock | $146.5K | -6K -0.26% | 2,073,395 0.65% of shares | medium |
| Apr 1, 2026 | Duchene Todd M Executive | Sell | Common Stock | $152.5K | -10K -0.49% | 2,047,089 0.64% of shares | medium |
| Jun 1, 2026 | Duchene Todd M Executive | Sell | Common Stock | $158.2K | -6K -0.26% | 2,078,895 0.65% of shares | medium |
| Apr 6, 2026 | Duchene Todd M Executive | Sell | Common Stock | $164.9K | -10K -0.49% | 2,037,089 0.63% of shares | medium |
| May 11, 2026 | Duchene Todd M Executive | Sell | Common Stock | $173.1K | -7K -0.37% | 1,970,348 0.61% of shares | medium |
| Apr 13, 2026 | Duchene Todd M Executive | Sell | Common Stock | $178.7K | -10K -0.47% | 2,027,489 0.63% of shares | medium |
| Apr 20, 2026 | Duchene Todd M Executive | Sell | Common Stock | $198.0K | -10K -0.50% | 2,000,348 0.62% of shares | medium |
| May 4, 2026 | Duchene Todd M Executive | Sell | Common Stock | $206.4K | -10K -0.50% | 1,980,448 0.62% of shares | medium |
| Apr 27, 2026 | Duchene Todd M Executive | Sell | Common Stock | $209.4K | -10K -0.50% | 1,990,348 0.62% of shares | medium |
| Jun 22, 2026 | Duchene Todd M Executive | Sell | Common Stock | $221.2K | -8K -0.37% | 2,051,295 0.64% of shares | medium |
| May 18, 2026 | Duchene Todd M Executive | Sell | Common Stock | $222.0K | -10K -0.49% | 1,960,748 0.61% of shares | medium |
| May 26, 2026 | Duchene Todd M Executive | Sell | Common Stock | $262.5K | -10K -0.48% | 2,088,895 0.65% of shares | medium |
| Jun 15, 2026 | Duchene Todd M Executive | Sell | Common Stock | $279.1K | -10K -0.48% | 2,058,995 0.64% of shares | medium |
| Apr 16, 2026 | Duchene Todd M Executive | Other | Common Stock | $319.4K | -17K -0.83% | 2,010,348 0.63% of shares | low |
| Mar 31, 2026 | Duchene Todd M Executive | Other | Common Stock | $1.46M | -98K -4.53% | 2,057,089 0.64% of shares | low |
| Mar 17, 2026 | Nygaard James P Jr Executive | Other | Common Stock | $1.52M | -93K -9.08% | 928,928 0.29% of shares | low |
| Mar 26, 2026 | Nygaard James P Jr Executive | Other | Common Stock | $1.62M | -99K -9.66% | 922,982 0.29% of shares | low |
| Dec 31, 2025 | Sullivan Adam Taylor CEO | Other | Common Stock | $1.77M | -118K -2.60% | 4,405,704 1.37% of shares | low |
| Dec 31, 2025 | Duchene Todd M Executive | Other | Common Stock | $2.11M | -140K -6.73% | 1,938,007 0.60% of shares | low |
| Jan 23, 2026 | Sullivan Adam Taylor CEO | Other | Common Stock | $5.16M | -274K -6.23% | 4,131,300 1.29% of shares | low |
| Jan 29, 2026 | Sullivan Adam Taylor CEO | Other | Common Stock | $5.16M | -275K -6.23% | 4,131,150 1.29% of shares | low |